2022
DOI: 10.26444/jpccr/146536
|View full text |Cite
|
Sign up to set email alerts
|

Radiological features of perivascular epithelioid cell tumours (PEComas) in a paediatric patient – Case report

Abstract: Introduction. Perivascular epithelioid cell tumour (PEComa) is a rare family of mesenchymal tumours composed of epithelioid cells. Due to its very rare occurrence, little information is available on the imaging characteristics of this type of lesion. Case Report. A 16-year-old patient was admitted for diagnosis of an incidentally found lesion of unclear origin on MRI of the lumbar spine. Targeted MRI revealed a pathological solid-cystic mass within the pelis, in the left rectovesical pouch, infiltrating the bl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Sirolimus (Fig. 2), empirical formula C 51 H 79 NO 13, also known as rapamycin with molar mass 914.17 g/mol and sold under the brand name Rapamune is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis [9], and treat perivascular epithelioid cell tumor (PEComa) [10]. It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants [11].Sirolimus was initially developed as an antifungal agent [12].…”
Section: Introductionmentioning
confidence: 99%
“…Sirolimus (Fig. 2), empirical formula C 51 H 79 NO 13, also known as rapamycin with molar mass 914.17 g/mol and sold under the brand name Rapamune is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis [9], and treat perivascular epithelioid cell tumor (PEComa) [10]. It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants [11].Sirolimus was initially developed as an antifungal agent [12].…”
Section: Introductionmentioning
confidence: 99%